Author:
Li Lin,Tang Chao,Ye Jianqing,Xu Da,Chu Chuanmin,Wang Lei,Zhou Qiwei,Gan Sishun,Liu Bing
Abstract
AbstractThe m6A methylation of mRNA has been demonstrated to interact with the “Reader”. YTH domain family is one of the readers containing five members involved in the progression of multiple tumors. The present study aimed to explore the YTH family's role in seventeen cancer types. Data were downloaded from The Cancer Genome Atlas (TCGA) dataset and analyzed by Software R 3.6.3. Using different bioinformatics methods, including analyses of the overall survival (OS) and disease-free survival (DFS), Gene Set Variation Analysis (GSVA) enrichment. Genomics of Drug Sensitivity in Cancer (GDSC), CIBERSORT algorithm, multivariate and lasso cox regression analysis our results reveal that, while the expression of the YTH domain family varies distinctively in different cancer types the expression of YTH family is upregulated in most cancer types, especially in liver cancer, and the liver cancer prediction model established herein includes YTHDF1 and YTHDF2. Therefore, the results of the present study have demonstrated that the YTH domain family has the potential to predict the prognosis of cancer and the sensitivity to immunotherapy.
Funder
Natural Science Foundation of Shanghai Municipality
Publisher
Springer Science and Business Media LLC
Reference44 articles.
1. Li, L. et al. ALKBH1 contributes to renal cell carcinoma progression by reducing N6-methyladenine of GPR137. Eur. J. Clin. Invest. 1, e13986 (2023).
2. Li, X., Ma, S., Deng, Y., Yi, P. & Yu, J. Targeting the RNA m(6)A modification for cancer immunotherapy. Mol. Cancer 21(1), 76 (2022).
3. Liao, S., Sun, H., Xu, C. & Domain, Y. T. H. A family of N(6)-methyladenosine (m(6)A) readers. Genom. Proteom. Bioinform. 16(2), 99–107 (2018).
4. Liu, S. et al. The roles and mechanisms of YTH domain-containing proteins in cancer development and progression. Am. J. Cancer Res. 10(4), 1068–1084 (2020).
5. Nishizawa, Y. et al. Oncogene c-Myc promotes epitranscriptome m(6)A reader YTHDF1 expression in colorectal cancer. Oncotarget 9(7), 7476–7486 (2018).